Overview
Prime contract obligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary, FY2021–FY2025
1 of 2 registrations
Largest industry, FY2021–FY2025
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
Click a bar to open its page.
Click a state to open its page.
- Maryland$120K · 59%
- North Dakota$84.7K · 41%
Insight 59% was performed in Maryland
The latest fiscal year is reported so far (hatched)
Hover over a year to see its value.
Insight $0 in FY2025
Largest company groups and registrations by prime obligations, FY2021–FY2025
Structure
Click a company to open its page.
Structure of Genovac Antibody Discovery LLC: company groups and registrations by prime obligations, FY2021–FY2025
2 registrationsRegistration: a company's record for doing federal work. One company can hold several (one per location); we count registrations until they are merged. Glossary; open them in the contractor directory (opens another page)
| Organization | Level | Location | Status | Prime obligations | Awards, all years |
|---|---|---|---|---|---|
| Genovac Antibody Discovery LLC | Parent company | $204,721 | 4 | ||
| Genovac Antibody Discovery LLC (opens another page) | Registration | Fargo, ND | Active | $204,721 | 2 |
| Genovac GMBH (opens another page) | Registration | Freiburg | Active | $0 | 2 |
Contracts
Contracts of Genovac Antibody Discovery LLC's registrations, latest action first
Use this to find a contract of any registration in the family.
Showing 1–4 of 4 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| HT942524P0103 | Genovac Antibody Discovery LLC | Defense Health Agency | $120,000 | Apr 8, 2026 | Jun 24, 2026 |
| HT942523P0030 | Genovac Antibody Discovery LLC | Defense Health Agency | $84,721 | Mar 27, 2024 | Dec 29, 2023 |
| HHSN263201700235A | Genovac GMBH | National Institutes of Health | $4,593 | Apr 6, 2017 | Jun 5, 2017 |
| HHSN263201700172A | Genovac GMBH | National Institutes of Health | $8,116 | Feb 2, 2017 | Apr 3, 2017 |
Agencies
Hover over a bar to see its value.
Insight Defense Health Agency paid 100%
Sub-agencies by prime obligations to Genovac Antibody Discovery LLC, FY2021–FY2025
Use this to see which sub-agencies pay the family's registrations; open one to see its offices.
1 sub-agencies paid the family
Showing 1–1 of 1 sub-agency
| FY2021–FY2025, US$ | FY2021–FY2025 | ||
|---|---|---|---|
| Defense Health Agency | $204,721 | 4 | |
Industries
Click a bar to open its page.
Insight 100% under Research and Development in Biotechnology (except Nanobiotechnology) (541714)
Industries by prime obligations, FY2021–FY2025
Use this to see what the family's registrations sell; open a code to see who else wins it.
Showing 1–1 of 1 industry code
| FY2021–FY2025, US$ | FY2021–FY2025 | |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $204,721 | 4 |
Places
Click a state to open its page.
- Maryland$120K · 59%
- North Dakota$84.7K · 41%
Insight 59% was performed in Maryland
States of performance by prime obligations since award, contracts active FY2021 on
Use this to see where the family's contract work is performed; open a state to see its contractors.
Showing 1–2 of 2 states
| Contracts active since FY2021; since award, US$ | ||
|---|---|---|
| Maryland | $120,000 | 1 |
| North Dakota | $84,721 | 1 |